Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
08/2010
08/12/2010US20100204194 Superoxide dismutase mimics for the treatment of ocular disorders and diseases
08/12/2010US20100203162 Method of preparing (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
08/12/2010US20100203007 Novel benzodiazepine derivatives
08/12/2010US20100202984 Naphthalene amidine imides
08/12/2010US20100202033 3h-naphth0 [2,1-b] pyrans as photochromic dichroic dyes and optical article containing them
08/12/2010US20100201259 Compound and method for producing the same, and ink composition, thin film, organic transistor and organic electroluminescence device, each using the same
08/12/2010CA2751535A1 Substituted spiro-amides as b1r modulators
08/12/2010CA2751402A1 Substituted indole compounds as bradykinin receptor 1 modulators
08/12/2010CA2751141A1 Inhibitors of jun n-terminal kinase
08/12/2010CA2750935A1 Heteroaryls and their use as pi3k inhibitors
08/12/2010CA2750714A1 Dihydroquinolinone derivatives
08/12/2010CA2749893A1 4-amino-7,8-dihydropyrido[4,3-d]pyrimidin-5(6h)-one derivatives
08/11/2010EP2216334A1 Hiv protease inhibiting sulfonamides
08/11/2010EP2216052A1 Use of novel compound having affinity for amyloid, and process for production of the same
08/11/2010EP2216051A1 Use of novel compound having affinity for amyloid, and process for production of the same
08/11/2010EP2216050A1 Utilization of novel compounds with amyloid affinity and method of producing the same
08/11/2010EP2216023A1 Condensed pyridine derivative and use thereof
08/11/2010EP2215910A1 Quorum sensing inhibitor
08/11/2010EP2215090A1 Purine derivatives useful as pi3 kinase inhibitors
08/11/2010EP2215089A1 [1h- pyrazolo [3, 4-b]pyridine-4-yl]-phenyle or -pyridin-2-yle derivatives as protein kinase c-theta
08/11/2010EP2215082A1 Phthalazine and pyrido ý3,4-d¨pyridaz ine compounds as h1 receptor antagonists
08/11/2010EP2215079A1 Inhibitors of c-fms kinase
08/11/2010EP2215068A1 Antidiabetic tricyclic compounds
08/11/2010EP2215064A1 Compounds for inhibiting ksp kinesin activity
08/11/2010EP2038356B1 Liquid hardening
08/11/2010CN1997649B Inhibitors of histone deacetylase
08/11/2010CN101803057A 有机场致发光器件 The organic light emitting devices
08/11/2010CN101801969A Indolyl pyrrolidines for the treatment of cancer
08/11/2010CN101801966A Bicyclic heteroaryl compounds and their use as kinase inhibitors
08/11/2010CN101801963A Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases
08/11/2010CN101801958A Heterocyclic amide compounds as protein kinase inhibitors
08/11/2010CN101801461A [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases
08/11/2010CN101801376A Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors
08/11/2010CN101798306A Uncaria alkaloid monomer as well as preparation method and application thereof
08/11/2010CN101798305A Tetrahydronaphthyridine derivates useful as histamine h3 receptor ligands
08/11/2010CN101190925B Copper complex, preparation method and application thereof
08/10/2010US7772397 derivatives of Hemiasterlin or Geodiamolide G; pyrido(3,4-B)indole amides; extraction from marine sponges; anti-mitotic and carcinogenic agent; cause mitotic arrest and produce abnormal mitotic spindles
08/10/2010US7772396 S)-zopiclone N-acetyl-D-glutamate, (S)-zopiclone N-acetyl-D-aspartate, or (S)-zopiclone N-acetyl-D-methionate; optically pure diastereoisomeric salt; hypnotic, sedative, tranquilizing, anxiolytic, muscle-relaxant and anticonvulsant properties
08/10/2010US7772267 Bicyclic modulators of androgen receptor function
08/10/2010US7772252 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands
08/10/2010US7772249 Imidazo[1,2-b]pyridazine compound
08/10/2010US7772248 Preparation and utility of substituted imidazopyridine compounds with hypnotic effects
08/10/2010US7772247 vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) receptor antagonists such as 1-(4-(2-(N-methoxy-N-methylcarbamoyl)thieno[3,2-b]pyridin-7yloxy)-3-fluorophenyl)-3-(2-phenylacetyl)thiourea, used as antiproliferative agents
08/10/2010US7772245 [N-hydroxy-4-(1,3,4,9-tetrahydro-2H-b-carbolin-2-yl)benzamide]; antiproliferative agent; cell cycle arrest, cellular differentiation, apoptosis and reversal of the transformed phenotype
08/10/2010US7772241 fused pyrido[3'.2':4.5]pyrrolo[1.2-c]pyrimidine's used for treating cancer in mammals
08/10/2010US7772236 Substituted pyrazoles
08/10/2010US7772234 Bicyclic inhibitors of MEK and methods of use thereof
08/10/2010US7772227 such as (R)-3-Cyclohexyl-2,3-dihydro-6-(4-ethylpiperazin-1-ylcarbonyl)pyrrolo[1,2,3-de]-1,4-benzoxazine hydrochloride salt, used as analgesics for the treatment of post-operative pain, chronic pain neuropathic pain, cancer pain and spasticity associated with multiple sclerosis
08/10/2010US7772226 such as 3-(2-Butynyl)-2-(piperazin-1-yl)-3,5-dihydroimidazo[4,5-d]pyridazin-4-one trifluoroacetate, used as dipeptidyl peptidase-IV (DPPIV) inhibitors for the treatment of obesity and diabetes
08/10/2010US7772225 N-sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditions
08/10/2010US7772224 Calcitonin gene-related peptide (CGRP) receptor antagonists such as N-[1-(2,3-Difluorobenzyl)-5-oxo-4-(2,22-trifluoroethyl)-1,4-diazepan-6-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide, used for treating headaches
08/10/2010US7772198 cycstic fibrosis transmembrane conductance regulators (CFTR); for treatment of cystic fibrosis, asthma or diarrhea
08/10/2010CA2535646C Cyclopropyl derivatives as nk3 receptor antagonists
08/10/2010CA2477967C Purine derivatives as kinase inhibitors
08/10/2010CA2451605C Diamine derivatives
08/10/2010CA2366800C Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
08/05/2010WO2010088195A1 Azaquinazolinediones useful as chymase inhibitors
08/05/2010WO2010088177A1 Inhibitors of akt activity
08/05/2010WO2010087761A1 2-aza-bicyclo[2.2.2]octane compounds and uses thereof
08/05/2010WO2010087471A1 Hydroxypyrazinecarboxamide derivatives
08/05/2010WO2010086280A1 Novel n-oxides of furanyl-oxadiazolyl-diazabicyclononane derivatives and their medical use
08/05/2010WO2010086279A1 Novel dibenzofuranyl-oxadiazolyl-diazabicyclononane derivatives and their medical use
08/05/2010WO2010086278A1 Novel benzodioxolyl-oxadiazolyl-diazabicyclononane derivatives and their medical use
08/05/2010WO2010086089A1 Metal complexes
08/05/2010WO2010045303A3 Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof
08/05/2010WO2009100872A8 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
08/05/2010US20100197924 Preparation of aminotetralin compounds
08/05/2010US20100197911 Nitrogen-Containing Aromatic Derivatives
08/05/2010US20100197909 Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in subtituent at 14-position
08/05/2010US20100197724 6.5 -pyrrolopiperidine tachykinin receptor antagonists
08/05/2010US20100197723 Bicyclic compounds and methods of making and using same
08/05/2010US20100197720 Heteroaryl-substituted diazatricycloalkanes and methods of use thereof
08/05/2010US20100197716 N-linked heterocyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
08/05/2010US20100197695 Antitumoral derivatives of et-743
08/05/2010US20100197692 Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
08/05/2010US20100197688 Epha4 rtk inhibitors for treatment of neurological and neurodegenerative disorders and cancer
08/05/2010US20100197684 Substituted heterocyclic compounds
08/05/2010US20100197682 Organic Compounds
08/05/2010US20100197681 Triazolopyridine Compounds and Their Use as Ask Inhibitors
08/05/2010US20100197678 Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions and Uses Thereof
08/05/2010US20100197668 1,2,3,4-TETRAHYDROPYRROLO[1,2-A]PYRAZINE-6-CARBOXAMIDE AND 2,3,4,5-TETRAHYDROPYRROLO[1,2-a][1,4]-DIAZEPINE-7-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
08/05/2010US20100197658 Pharmaceutical use of fused 1,2,4-triazoles
08/05/2010US20100197634 Inhibitors of janus kinases
08/05/2010US20100197591 4-AMINO-7,8-DIHYDROPYRIDO[4,3-d]PYRIMIDIN-5(6H)-ONE DERIVATIVES
08/05/2010US20100197590 4-AMINO-7,8-DIHYDROPYRIDO[4,3-d]PYRIMIDIN-5(6H)-ONE DERIVATIVES
08/05/2010US20100196714 Process for preparing quinoline compounds and products obtained therefrom
08/05/2010US20100196319 4, 5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections
08/05/2010US20100193774 Quinoid Compounds and Their Use in Semiconducting Matrix Materials, Electronic and Optoelectronic Structural Elements
08/05/2010CA2750051A1 Inhibitors of akt activity
08/04/2010EP2213672A1 Novel compound having affinity for amyloid
08/04/2010EP2213671A1 Novel compound having affinity for amyloid
08/04/2010EP2212324A1 Compounds having antiviral properties
08/04/2010EP2212323A2 Imidazo [1,2-a] pyridine derivatives useful as alk inhibitors
08/04/2010EP2212321A2 (1,4-diaza-bicyclo[3.2.2]non-6-en-4-yl)-heterocyclyl-methanone ligands for nicotinic acetylcholine receptors, useful for the treatment of disease
08/04/2010EP2212318A1 Thiazole derivatives as protein kinase inhibitors
08/04/2010EP2212297A1 Inhibitors of protein kinases
08/04/2010EP2212282A1 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
08/04/2010EP2211620A1 Therapeutic compounds
08/04/2010EP2211615A1 Pyridosulfonamide derivatives as pi3 kinase inhibitors
08/04/2010EP2010506B1 Diazepan derivatives modulators of chemokine receptors